Article Information
vol. 8 no. 362 362ra146
- Received for publication April 13, 2016
- Accepted for publication October 7, 2016
- .
Author Information
- Nadine Mykicki1,2,
- Alexander M. Herrmann2,3,
- Nicholas Schwab3,
- René Deenen4,
- Tim Sparwasser5,
- Andreas Limmer6,
- Lydia Wachsmuth7,
- Luisa Klotz3,
- Karl Köhrer4,
- Cornelius Faber2,7,8,
- Heinz Wiendl2,3,8,
- Thomas A. Luger1,2,
- Sven G. Meuth2,3,8,* and
- Karin Loser1,2,8,*,†
- 1Department of Dermatology, University of Münster, 48149 Münster, Germany.
- 2Cells in Motion—Cluster of Excellence, University of Münster, 48149 Münster, Germany.
- 3Department of Neurology, University of Münster, 48149 Münster, Germany.
- 4Biological and Medical Research Center, University of Düsseldorf, 40225 Düsseldorf, Germany.
- 5Institute of Infection Immunology, TWINCORE Centre for Experimental and Clinical Infection Research, 30625 Hannover, Germany.
- 6Clinic for Orthopedic and Trauma Surgery, University Clinic of Bonn, 53127 Bonn, Germany.
- 7Department of Clinical Radiology, University of Münster, 48149 Münster, Germany.
- 8CRC1009 Breaking Barriers and CRC-TR 128 Multiple Sclerosis, University of Münster, 48149 Münster, Germany.
- ↵†Corresponding author. Email: loserk{at}uni-muenster.de